Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing.
Hopewell Therapeutics has raised $2.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
Hopewell Therapeutics's investors include 5Y Capital, BOPU, IMO Ventures, Hike Capital, WS Investment Company.
Hopewell Therapeutics is headquartered in Woburn, United States.
Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing.
Hopewell Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hopewell Therapeutics — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/hopewell-therapeutics. Accessed September 29, 2026.
VCBacked. (2025). Hopewell Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/hopewell-therapeutics
{{cite web |title=Hopewell Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/hopewell-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated